Inventor · disambiguated record
Tomoichi Shinohara
Also filed as: SHINOHARA TOMOICHI
18 granted patents·7 pending applications·156 citations·filing 1995–2025
93Inventor score
Top patents by PatentIndex Score
25 records- 0186US2025361224A1Pyrimidine compoundOTSUKA PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 0282US10000450B2N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsOTSUKA PHARMA CO LTD·Filed 2017·Granted Jun 19, 2018·3 cites·6 claims
- 0381US6096736ABenzazepine derivatives with vasopressin agonistic activityOTSUKA PHARMA CO LTD·Filed 1996·Granted Aug 1, 2000·54 cites·24 claims
- 0479US8084442B2N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsKURIMURA MUNEAKI·Filed 2006·Granted Dec 27, 2011·4 cites·9 claims
- 0578US10800758B2Pyrimidine compoundOTSUKA PHARMA CO LTD·Filed 2018·Granted Oct 13, 2020·1 cites·88 claims
- 0678US8815871B2N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsOTSUKA PHARMA CO LTD·Filed 2013·Granted Aug 26, 2014·3 cites·6 claims
- 0778US8420623B2N, N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsKURIMURA MUNEAKI·Filed 2011·Granted Apr 16, 2013·4 cites·10 claims
- 0877US10603331B2Method of treating disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamineOTSUKA PHARMA CO LTD·Filed 2018·Granted Mar 31, 2020·1 cites·5 claims
- 0977US6096735ABenzoheterocyclic derivativesOTSUKA PHARMA CO LTD·Filed 1995·Granted Aug 1, 2000·36 cites·17 claims
- 1077US2023138411A1Pyrimidine compoundOTSUKA PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1176US6140330AThiazole derivativeOTSUKA PHARMA CO LTD·Filed 1997·Granted Oct 31, 2000·23 cites·29 claims
- 1274US7777038B2Carbostyril compoundOTSUKA PHARMA CO LTD·Filed 2005·Granted Aug 17, 2010·3 cites·27 claims
- 1374US6642223B2Benzoheterocyclic derivativesOTSUKA PHARMA CO LTD·Filed 2001·Granted Nov 4, 2003·6 cites·38 claims
- 1471US11273168B2Methods of treating anxiety by administering a substituted quinoloneOTSUKA PHARMA CO LTD·Filed 2020·Granted Mar 15, 2022·0 cites·6 claims
- 1569US8362252B2Carbostyril compoundOTSUKA PHARMA CO LTD·Filed 2009·Granted Jan 29, 2013·1 cites·7 claims
- 1668US2025304558A1Heterocyclic compounds for the treatment of epilepsyOTSUKA PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 1767US2020399245A1Pyrimidine compoundOTSUKA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1864US12391674B2Heterocyclic compounds for the treatment of epilepsyOTSUKA PHARMA CO LTD·Filed 2019·Granted Aug 19, 2025·0 cites·17 claims
- 1963US6335327B1Benzoheterocyclic derivativesOTSUKA PHARMACEUTICALS CO LTD·Filed 1999·Granted Jan 1, 2002·17 cites·20 claims
- 2062US2018258038A1N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsOTSUKA PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 2160US10064879B2Method for treating depression and/or depression status with substituted quinoxaline compoundsOTSUKA PHARMA CO LTD·Filed 2017·Granted Sep 4, 2018·0 cites·7 claims
- 2260US9611214B2N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsKURIMURA MUNEAKI·Filed 2014·Granted Apr 4, 2017·0 cites·7 claims
- 2356US9090572B2Substituted quinoxalines compoundsITO NOBUAKI·Filed 2011·Granted Jul 28, 2015·0 cites·7 claims
- 2454US2016058757A1Heterocyclic compounds for treating or preventing disorers caused by reduced neurotransmission of serotonin, norephnephrine or dopamineOTSUKA PHARMA CO LTD·Filed 2015·Application pending·0 cites
- 2552US2024409519A1Hydrogenated quinoxalinesOTSUKA PHARMA CO LTD·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →